STAT argues subscription pricing could broaden access to lenacapavir for HIV prevention while controlling costs, citing the hepatitis C Netflix model as precedent.
Subscription pricing could expand access to HIV prevention breakthrough while controlling costs.
The ‘Netflix model’ has worked for hepatitis C treatment and can work for lenacapavir.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare